Lecomkafusp alfa Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2491; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The latest addition to our line of biotech products. This highly advanced biosimilar offers a powerful solution for researchers in the biotechnology field, with its superior quality and reliable results.
Lecomkafusp alfa Biosimilar – Research Grade is a recombinant fusion protein that acts as a potent inhibitor of the complement system. It is designed to target the C5 component of the complement cascade, which plays a crucial role in immune response and inflammation. By blocking C5, Lecomkafusp alfa Biosimilar effectively reduces the activation of the complement system, providing a valuable tool for studying its role in various biological processes.
This biosimilar has a wide range of applications in the field of biotechnology. Its primary use is in the study of immune response and inflammatory diseases, as it allows researchers to manipulate the complement system and observe its effects. It is also valuable in the development of new therapeutics for conditions such as autoimmune disorders, transplant rejection, and infectious diseases.
The versatility of Lecomkafusp alfa Biosimilar – Research Grade makes it an essential tool for various experimental studies. Its ability to modulate the complement system allows researchers to investigate its involvement in different biological processes, such as tissue regeneration, wound healing, and cancer progression. Additionally, this biosimilar can be used to evaluate the efficacy of potential complement-targeting drugs and explore new therapeutic approaches.
With its high purity and consistent performance, Lecomkafusp alfa Biosimilar – Research Grade is a top choice for biotech researchers seeking reliable and accurate results. Its cost-effective price and easy handling make it a valuable addition to any laboratory.
In summary, Lecomkafusp alfa Biosimilar – Research Grade is a cutting-edge biosimilar with a specific biological function of inhibiting the complement system. Its main applications include studying immune response and inflammatory diseases, while its experimental use cases allow for a wide range of research possibilities. Choose Lecomkafusp alfa Biosimilar – Research Grade for top-quality results and a deeper understanding of the complement system.
ProteoGenix catalogue number PX-TA2491. For research use only.
Target: Lecomkafusp alfa Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal Antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
